Agreements with WELL Health to Sell Clinical Assets T.DRDR NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
- MCI will undergo a series of transactions that will empower its emerging AI-powered data science business, which aims to help clinicians safely and securely unlock the power of their data to improve patient outcomes.
- MCI will sell a significant portion of its clinical assets to WELL Health Clinic Network Inc., a subsidiary of WELL Health Technologies Corp., and obtain new financing as well as a strategic alliance with WELL; positioning it to emerge as a key national platform in the multi-billion dollar rare and complex disease detection digital marketplace.
- MCI will have a healthy balance sheet at closing, with positive working capital and a pipeline of opportunities to grow organically and inorganically in a marketplace being quickly disrupted by AI.
TORONTO, July 20, 2023 (GLOBE NEWSWIRE) -- MCI Onehealth Technologies Inc. (“MCI” or the “Company”) (TSX: DRDR), a clinician-led healthcare technology company focused on increasing access to and quality of healthcare, announced today that it has entered into definitive agreements with WELL Health Technologies Corp. (“WELL”), that will result in MCI selling a significant portion of its clinical assets to WELL Health Clinic Network Inc., obtaining new financing and positioning MCI to emerge as a key national platform with a strong focus on AI-powered healthcare technology and clinical research (the “Transaction”).
MCI Onehealth Enters into Agreements with WELL Health to (globenewswire.com)